SLC5A2 and chronic kidney disease: As renal impairment or tubular damage progresses, it is possible that reabsorption of 1,5-AG would be reduced as a result of decreases in SGLT2 number and aggravating damage of glucose cotransporters, which might be responsible for the reduction of the serum level of 1,5-AG in patients with CKD.